Non-involuting congenital hemangioma have angioproliferative features of both congenital vascular malformations and of vascular tumors- insights from apoptosis, autophagy and senescence
DOI:
https://doi.org/10.20956/nmsj.v10i1.44711Abstract
Backgrounds: Non-Involuting Congenital Hemangiomas (NICH) are benign vascular lesions distinguished by the proliferation of micro-vessels. Currently, the underlying pathophysiology and connection with congenital vascular malformations remain uncertain. This study aims to explore age-related discrepancies in NICH and compare them with malformations by examining histological characteristics and assessing markers for cell death, maturation and proliferation. The goal is to ascertain whether NICH should be classified as vascular tumors or vascular malformations, in order to properly classify them within the wide spectrum of vascular anomalies.
Methods: Paraffin blocks of 36 clinically documented cases of NICH (n=12) and congenital vascular malformations (n=24) were immunostained using antibodies against cell-death (C-Caspase-3) and cell-cycle related proteins (Ki67, p62, LC3B, p21, p27), and immunodouble stained with smooth muscle actin antibody for identifying immunolocalization with vessel walls. Three independent observers conducted semi-quantitative scoring of stained samples. Statistical analysis was employed to compare differences between NICH in two age groups (young and old), and congenital vascular malformations.
Results: Clinical history in combination with histology and Ki67 categorized the lesions into four groups: NICH younger ages (n=7), NICH old ages (n=5), non-proliferative vascular malformations (n=12), and proliferative vascular malformations (n=12). C-Caspase-3 and LC3B showed significantly higher expression in the younger age group of NICH (p<0.05) and proliferative AVM (p<0.05). The senescence marker p21 was elevated only in proliferative AVM, while p27 exhibited higher expression in both NICH and proliferative AVM compared to non-proliferative vascular malformations.
Conclusions: This study revealed distinct expression patterns of cell cycle related proteins in different types of benign vascular anomalies and within the same type across different age groups. NICH, despite sharing certain clinical characteristics (onset in utero, no tendency to regress) with congenital vascular malformations, displayed a persistent vasoproliferative behavior and different patterns of apoptosis, autophagy and senescence. These findings may endorse the view that NICH should not be classified as congenital vascular malformations. However, NICH revealed similarities with AVM subtypes harbouring a vasoproliferative component. Therefore, it could be argued whether proliferative components of AVM are really part of the developmental disorder itself , or could represent a (reactive) epiphenomenon.
References
1. Lee PW, Frieden IJ, Streicher JL, McCalmont T, Haggstrom AN. Characteristics of noninvoluting congenital hemangioma: A retrospective review. Journal of the American Academy of Dermatology. 2014;70(5):899–903. https://doi.org/10.1016/j.jaad.2014.01.860 PMID: 24630000
2. Nasseri E, Piram M, McCuaig CC, Kokta V, Dubois J, Powell J. Partially involuting congenital hemangiomas: A report of 8 cases and review of the literature. Journal of the American Academy of Dermatology. 2014;70(1):75–9. https://doi.org/10.1016/j.jaad.2013.09.018
3. Enjolras O, Mulliken JB, Boon LM, Wassef M, Kozakewich HPW, Burrows PE. Noninvoluting congenital hemangioma: A rare cutaneous vascular anomaly. Vol. 107, Plastic and Reconstructive Surgery. 2001. p. 1647–54. https://doi.org/10.1097/00006534-200106000-00002 PMID: 11391180
4. Larsen AK, Damsgaard TE, Hedelund L. Classification of vascular anomalies. Ugeskrift for laeger. 2018;180(36). https://doi.org/10.1177/014556130608500602 PMID: 30187855
5. Cossio ML, Dubois J, McCuaig CC, Coulombe J, Hatami A, Marcoux D, et al. Non-involuting congenital hemangiomas (NICH) with postnatal atypical growth: A case series. Pediatric Dermatology. 2019;36(4):466–70. https://doi.org/10.1111/pde.13837 PMID: 31033005
6. Berenguer B, Mulliken JB, Enjolras O, Boon LM, Wassef M, Josset P, et al. Rapidly Involuting Congenital Hemangioma: Clinical and Histopathologic Features. Pediatric and Developmental Pathology. 2003;6(6):495–510. https://doi.org/10.1007/s10024-003-2134-6 PMID: 15018449
7. Boull C, Maguiness SM. Congenital hemangiomas. Seminars in Cutaneous Medicine and Surgery. 2016;35(3):124–7. https://doi.org/10.12788/j.sder.2016.045 PMID: 27607320
8. Wildgruber M, Sadick M, Müller-Wille R, Wohlgemuth WA. Vascular tumors in infants and adolescents. Insights into Imaging. 2019;10(1):6–8. https://doi.org/10.1186/s13244-019-0718-6
9. Mulliken JB, Enjolras O. Congenital hemangiomas and infantile hemangioma: Missing links. Journal of the American Academy of Dermatology. 2004;50(6):875–82. https://doi.org/10.1016/j.jaad.2003.10.670 PMID: 15153887
10. Meijer-Jorna LB, Van Der Loos CM, Teeling P, De Boer OJ, Florquin S, Van Der Horst CMAM, et al. Proliferation and maturation of microvessels in arteriovenous malformations - Expression patterns of angiogenic and cell cycle-dependent factors. Journal of Cutaneous Pathology. 2012;39(6):610–20. https://doi.org/c
11. Razon MJ, Kräling BM, Mulliken JB, Bischoff J. Increased apoptosis coincides with onset of involution in infantile hemangioma. Microcirculation. 1998;5(2–3):189–95. https://doi.org/10.1038/sj.mn.7300009 PMID: 9789259
12. Frischer JS, Huang J, Serur A, Kadenhe A, Yamashiro DJ, Kandel JJ. Biomolecular Markers and Involution of Hemangiomas. Journal of Pediatric Surgery. 2004;39(3):400–4. https://doi.org/10.1016/j.jpedsurg.2003.11.043 PMID: 15017560
13. North PE. Pediatric vascular tumors and malformations. Surgical Pathology Clinics. 2010;3(3):455–94. https://doi.org/10.1016/j.path.2010.07.002
14. Adams DM, Brandão LR, Peterman CM, Gupta A, Patel M, Fishman S, et al. Vascular anomaly cases for the pediatric hematologist oncologists—An interdisciplinary review. Pediatric Blood and Cancer. 2018;65(1):1–9. https://doi.org/10.1002/pbc.26716 PMID: 28727248
15. Pertiwi KR, de Boer OJ, Mackaaij C, Pabittei DR, de Winter RJ, Li X, et al. Extracellular traps derived from macrophages, mast cells, eosinophils and neutrophils are generated in a time-dependent manner during atherothrombosis. Journal of Pathology. 2019;247(4):505–12. https://doi.org/10.1002/path.5212 PMID: 30506885
16. Omori Y, Ono Y, Kobayashi T, Motoi F, Karasaki H, Mizukami Y, et al. How does intestinal-type intraductal papillary mucinous neoplasm emerge? CDX2 plays a critical role in the process of intestinal differentiation and progression. Virchows Archiv. 2020;477(1):21–31. https://doi.org/10.1007/s00428-020-02806-8 PMID: 32291497
17. Li X, Li J, Wang M, Wang J, Wang L, He H, et al. Case Report: A Rare Abdominopelvic Arteriovenous Malformation: Originating From Splenic Artery and Draining Into Portal Vein. Frontiers in Cardiovascular Medicine. 2022;9(June):1–6. https://doi.org/10.3389/fcvm.2022.916096
18. Bresciani A, Spiezia MC, Boggio R, Cariulo C, Nordheim A, Altobelli R, et al. Quantifying autophagy using novel LC3B and p62 TR-FRET assays. PLoS ONE. 2018;13(3):1–18. https://doi.org/10.1371/journal.pone.0194423 PMID: 29554128
19. Galluzzi L, Green DR. Autophagy-Independent Functions of the Autophagy Machinery. Cell. 2019;177(7):1682–99. https://doi.org/10.1016/j.cell.2019.05.026 PMID: 31199916
20. Yang ZJ, Chee CE, Huang S, Sinicrope F. Autophagy modulation for cancer therapy. Cancer biology & therapy. 2011 Jan;11(2):169–76. https://doi.org/10.4161/cbt.11.2.14663 PMID: 21263212
21. De Meyer GRY, Grootaert MOJ, Michiels CF, Kurdi A, Schrijvers DM, Martinet W. Autophagy in vascular disease. Circulation research. 2015 Jan;116(3):468–79. https://doi.org/10.1161/CIRCRESAHA.116.303804 PMID: 25634970
22. Bao J, Li G, Yuan X, Li PL, Gulbins E. Contribution of p62 to Phenotype Transition of Coronary Arterial Myocytes with Defective Autophagy. Cellular Physiology and Biochemistry. 2017;41(2):555–68. https://doi.org/10.1159/000457877 PMID: 28214847
23. Utami AM, Azahaf S, Boer OJ De, Horst CMAM Van Der, Meijer-jorna LB. A literature review of microvascular proliferation in arteriovenous malformations of skin and soft tissue. Journal of Clinical and Translation Research. 2021;7(4):540–57. https://doi.org/10.18053/jctres.07.202104.011 PMID: 34541367
24. Xi H, Wang S, Wang B, Hong X, Liu X, Li M, et al. The role of interaction between autophagy and apoptosis in tumorigenesis (Review). Oncology Reports. 2022;48(6):1–16. https://doi.org/10.3892/or.2022.8423 PMID: 36222296
25. Yang ZY, Simari RD, Perkins ND, San H, Gordon D, Nabel GJ, et al. Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury. Proceedings of the National Academy of Sciences of the United States of America. 1996;93(15):7905–10. https://doi.org/10.1073/pnas.93.15.7905 PMID: 8755575
26. Goukassian D, DÍEz‐Juan A, Asahara T, Schratzberger P, Silver M, Murayama T, et al. Overexpression of p27 Kip1 by doxycycline‐regulated adenoviral vectors inhibits endothelial cell proliferation and migration and impairs angiogenesis . The FASEB Journal. 2001;15(11):1877–85. https://doi.org/10.1096/fj.01-0065com PMID: 11532967
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Amalia Mulia Utami, Gonca Cinkara, Kartika Ratna Pertiwi, Max M. Lokhorst, Onno J. de Boer , Chantal MAM van der Horst , Lorine B. Meijer-Jorna , Allard C. van der Wal
This work is licensed under a Creative Commons Attribution 4.0 International License.
